Information
-
Trademark
-
98610677
-
International Classifications
-
Filing Date
June 20, 2024
a year ago
-
Transaction Date
July 16, 2025
3 months ago
-
Status Date
July 15, 2025
3 months ago
-
Published for Opposition Date
May 20, 2025
5 months ago
-
Location Date
July 15, 2025
3 months ago
-
Status Code
688
-
Current Location
INTENT TO USE SECTION
Employee Name
REGAN, BRENDAN
-
Attorney Name
Evan A. Raynes
Law Office Assigned Location Code
M40
-
Owners
Mark Drawing Code
4
Mark Identification
BASILEA PHARMACEUTICA
Case File Statements
- GS0051: diagnostic reagents for medical or veterinary purposes; pharmaceutical and veterinary products and preparations for the treatment and prevention of dermatological conditions, namely, eczema, inflammation, infection, warts, psoriasis, aging of the skin, ultra violet radiation and cancer; pharmaceutical and veterinary products and preparations for the treatment and prevention of infections caused by bacteria, fungi, viruses, and rheumatoid arthritis; pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of oncology; pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of gastroenterology; pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of neurology; pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of gynecology; pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of urology; pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of cardiology; pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of endocrinology; pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of nephrology; pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of hematology; pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of allergy; pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of immunology; pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of psychiatry; pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of anesthesiology; pharmaceutical and veterinary products and preparations for the treatment and prevention of diseases, disorders and conditions in the area of rheumatology; diagnostic preparations for medical purposes; clinical medical reagents
- GS0011: chemical substances for use in the manufacture of pharmaceutical preparations for the treatment of dermatological conditions and for the treatment of infections and diseases; chemical substances for use in research and development of pharmaceuticals for the treatment of dermatological conditions and for the treatment of infections and diseases; diagnostic preparations for scientific clinical use; diagnostic reagents, other than for medical or veterinary purposes
- DS0000: "PHARMACEUTICA"
- GS0421: Research and development services for third parties in the field of chemical substances, pharmaceutical and veterinary products and preparations
Case File Event Statements
-
6/20/2024 - a year ago
1 - NEW APPLICATION ENTERED
Type: NWAP
-
1/14/2025 - 9 months ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
1/25/2025 - 9 months ago
6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
1/25/2025 - 9 months ago
5 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
1/13/2025 - 9 months ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
3/31/2025 - 7 months ago
8 - EXAMINERS AMENDMENT E-MAILED
Type: GNEA
-
3/31/2025 - 7 months ago
10 - EXAMINER'S AMENDMENT ENTERED
Type: XAEC
-
1/25/2025 - 9 months ago
4 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
3/31/2025 - 7 months ago
7 - EXAMINERS AMENDMENT -WRITTEN
Type: CNEA
-
3/31/2025 - 7 months ago
9 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Type: GNEN
-
4/21/2025 - 6 months ago
11 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
5/14/2025 - 5 months ago
12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
5/20/2025 - 5 months ago
13 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
5/20/2025 - 5 months ago
14 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
7/15/2025 - 3 months ago
15 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Type: NOAM